Free Trial

60 Degrees Pharmaceuticals (SXTP) Short Interest Ratio & Short Volume

60 Degrees Pharmaceuticals logo
$2.48 -0.20 (-7.46%)
Closing price 04:00 PM Eastern
Extended Trading
$2.47 -0.01 (-0.40%)
As of 04:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

60 Degrees Pharmaceuticals Short Interest Data

60 Degrees Pharmaceuticals (SXTP) has a short interest of 426,600 shares, representing 30.91% of the float (the number of shares available for trading by the public). This marks a 1,360.96% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 547,276 shares to cover all short positions.

Current Short Interest
426,600 shares
Previous Short Interest
29,200 shares
Change Vs. Previous Month
+1,360.96%
Dollar Volume Sold Short
$1.47 million
Short Interest Ratio
0.2 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
1,473,000 shares
Float Size
1,380,000 shares
Short Percent of Float
30.91%
Today's Trading Volume
67,684 shares
Average Trading Volume
547,276 shares
Today's Volume Vs. Average
12%
Short Selling 60 Degrees Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for 60 Degrees Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SXTP Short Interest Over Time

SXTP Days to Cover Over Time

SXTP Percentage of Float Shorted Over Time

60 Degrees Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2025426,600 shares $1.47 million +1,361.0%30.9%0.2 $3.45
3/31/202529,200 shares $53,728.00 -43.2%2.1%0 $1.84
3/15/202551,400 shares $97,146.00 +252.1%3.7%0.1 $1.89
2/28/202514,600 shares $26,426.00 -38.7%1.2%0 $1.81
2/15/202523,800 shares $70,329.00 -94.6%6.5%0.1 $2.96
1/31/2025443,900 shares $322,404.57 +112.0%28.6%0.2 $0.73
1/15/2025209,400 shares $189,507.00 +33.7%11.4%0.4 $0.91
12/31/2024156,600 shares $202,014.00 -39.2%8.4%0.3 $1.29
12/15/2024257,700 shares $363,357.00 +412.3%13.9%0.8 $1.41
11/30/202450,300 shares $53,318.00 -42.2%2.6%0.3 $1.06
11/15/202487,000 shares $78,039.00 +133.2%5.6%0.9 $0.90
10/31/202437,300 shares $28,758.30 +126.1%2.3%0.1 $0.77
10/15/202416,500 shares $15,675.00 -47.3%1.0%0 $0.95
9/30/202431,300 shares $39,125.00 -42.4%1.9%0 $1.25
9/15/202454,300 shares $74,955.72 -24.6%3.4%0.1 $1.38
8/31/202472,000 shares $96,480.00 -31.3%4.7%0.1 $1.34
8/15/2024104,800 shares $172,920.00 -78.2%6.9%0.1 $1.65
7/31/2024479,900 shares $70,785.25 -34.5%3.1%0.1 $0.15
7/15/2024732,200 shares $168,113.12 +166.4%7.9%0.2 $0.23
6/30/2024274,900 shares $69,522.21 -15.0%3.0%0.4 $0.25
6/15/2024323,400 shares $88,320.54 +40.4%3.5%0.7 $0.27
5/31/2024230,400 shares $67,276.80 +159.2%2.5%0.5 $0.29
5/15/202488,900 shares $18,944.59 -22.4%1.0%0.3 $0.21
4/30/2024114,500 shares $26,312.10 -12.4%1.3%0.5 $0.23
4/15/2024130,700 shares $33,982.00 +95.1%1.5%0.4 $0.26
3/31/202467,000 shares $17,487.00 +2.3%0.8%0.2 $0.26
3/15/202465,500 shares $15,556.25 -56.9%1.5%0.1 $0.24
2/29/2024152,000 shares $41,085.60 -40.5%4.6%0.2 $0.27
2/15/2024255,300 shares $81,593.88 -50.5%7.8%0.3 $0.32
1/31/2024515,700 shares $144,602.28 No Change15.7%0.7 $0.28

SXTP Short Interest - Frequently Asked Questions

What is 60 Degrees Pharmaceuticals' current short interest?

Short interest is the volume of 60 Degrees Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 426,600 shares of SXTP short. 30.91% of 60 Degrees Pharmaceuticals' shares are currently sold short. Learn More on 60 Degrees Pharmaceuticals' current short interest.

What is a good short interest percentage for 60 Degrees Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 30.91% of 60 Degrees Pharmaceuticals' floating shares are currently sold short.

Is 60 Degrees Pharmaceuticals' short interest increasing or decreasing?

60 Degrees Pharmaceuticals saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 426,600 shares, an increase of 1,361.0% from the previous total of 29,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is 60 Degrees Pharmaceuticals' float size?

60 Degrees Pharmaceuticals currently has issued a total of 1,473,000 shares. Some of 60 Degrees Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. 60 Degrees Pharmaceuticals currently has a public float of 1,380,000 shares.

How does 60 Degrees Pharmaceuticals' short interest compare to its competitors?

30.91% of 60 Degrees Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to 60 Degrees Pharmaceuticals: Mannatech, Incorporated (0.95%), Allarity Therapeutics, Inc. (11.15%), Natural Alternatives International, Inc. (0.09%), Chemomab Therapeutics Ltd. (0.81%), Edesa Biotech, Inc. (0.90%), Sol-Gel Technologies Ltd. (0.50%), Equillium, Inc. (1.10%), Lipocine Inc. (1.39%), Cingulate Inc. (4.50%), Unity Biotechnology, Inc. (4.83%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short 60 Degrees Pharmaceuticals stock?

Short selling SXTP is an investing strategy that aims to generate trading profit from 60 Degrees Pharmaceuticals as its price is falling. SXTP shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against 60 Degrees Pharmaceuticals?

A short squeeze for 60 Degrees Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SXTP, which in turn drives the price of the stock up even further.

How often is 60 Degrees Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SXTP, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:SXTP) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners